Sno.
|
Test Name
|
Amount
|
Min Qty
|
Ref. Value
|
1
|
FABP ( Fatty Acid Binding Protein) |
2000 |
|
Interpretation:
FABP : Positive - Myocardial Infarction likely FABP : Negative - MI Not likely.
FABP is an early marker for Myocardial Infarction and is positive from 30 minutes after apperance of chest pain and persisits till 24 hours.A neagtive FABP is possible when the test is done outside the above time window.
|
2 |
FACIAL NERVE CONDUCTION STUDY AND BLINK REFLEX |
3000 |
|
|
3
|
Factor XII Functional |
4000 |
|
|
4 |
Factor II Assay(Citrated Plasma) |
1500 |
|
70 - 120 %
|
5
|
Factor IX Assay(Citrated Plasma) |
3000 |
|
70 to 120 %
Hemophilia B / Christmas disease (Factor IX deficiency) is a severe congenital X- linked bleeding disorder affecting 1:25,000 to 30,000 males. The disease is characterized by hemarthrosis, soft tissue hematomas, easy bruising, excessive bleeding during surgery, dental extraction and poor wound healing. Factor IX activity levels during childhood remain at about 75% of adult levels. There is a 25% increment in Factor IX expression that begins at puberty in both sexes.
Decreased levels :
1.Inherited Christmas Disease / Hemophilia B 2.Acquired due to Vitamin K deficiency, liver disease, warfarin therapy, Nephritic syndrome
Increased levels :
1.Advancing age & use of Oral contraceptives
|
6 |
Factor V Assay(Citrated Plasma) |
1500 |
|
70 - 120 %
|
7
|
FACTOR V LEIDEN |
5500 |
2 ml
|
|
8 |
Factor VII Assay(Citrated Plasma) |
3500 |
|
70 - 120 %
Decreased levels
1.Inherited deficiency
2.Acquired due to liver disease, vitamin K deficiency or anticoagulant therapy
Increased levels
Pregnancy, Oral contraceptives, hyperlipidemia, ageing & obesity
|
9
|
Factor VIII Assay(Citrated Plasma) |
2000 |
|
60 to 150 %
Hemophilia A (Factor VIII deficiency) is the most common severe congenital bleeding X-linked disorder affecting 1:5000 to 10,000 males. Females are usually carriers but can have Hemophilia A if there is imbalanced Lyonization of the normal X-chromosome, Turner's syndrome or daughters of an affected male and a carrier female. The disease is characterized by hemarthrosis, soft tissue hematomas, easy bruising, excessive bleeding during surgery, dental extraction and poor wound healing.
Note ---- 1. Clinically normal individuals may show concentrations between 30-45% 2. Results should be clinically correlated 3. Test conducted on Citrated plasma
|
10 |
Factor X Assay(Citrated Plasma) |
5000 |
|
70 - 120 %
|
11
|
Factor XIII Assay(Citrated Plasma) |
500 |
|
|
12 |
Factor XIII Screen 5M Urea Clot StabilityI Test |
500 |
|
(at 37 c - 24 Hours)
|
13
|
FALLOPIAN TUBES AND OVARIES
|
800 |
|
|
14 |
False acacia[Robina psedoacacia](t28)(f208) - SPEC |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
15
|
Fatty Acid Oxidation Disorders by TMS |
1000 |
|
|
16 |
FDP (FIBRIN DEGRADATION PRODUCTS) |
500 |
1 ml
|
LESS THAN 5.0 ug/ml : NEGATIVE MORE THAN OR EQUAL TO 5.0 ug/ml : POSITIVE
|
17
|
FE Sodium |
200 |
|
Less than 1% :Pre Renal Disease
More than 2-3 % :Acute tubular necrosis or other postrenal disease.
|
18 |
Fe Uric Acid
|
200 |
|
|
19
|
Feacal H.Pylori Antigen |
1000 |
|
|
20 |
FEMUR AP/LAT (RIGHT)
|
500 |
|
|
21
|
FERRITIN |
500 |
1 ml
|
Males : 30 - 400 ng/ml
Females : 13 - 150 ng/ml
|
22 |
Fetal Doppler
|
1000 |
|
|
23
|
Fetal Anomolies Scan (24 weeks)
|
1000 |
|
|
24 |
Fetal Growth Assessment /IUGR
|
1000 |
|
|
25
|
FGF - 23 (Fibroblast Growth Factor) |
4000 |
|
|
26 |
FGFR I By FISH |
3500 |
|
|
27
|
FIBRINOGEN |
900 |
1 ML
|
180 - 350 mg/dl
|
28 |
Fish (f3) - SPECIFIC IgE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
29
|
FISH for MMD2 |
6000 |
|
|
30 |
FISH Panel for Chromosomes 13,18,21, X & Y |
7500 |
|
|
31
|
FISTULA
|
500 |
|
|
32 |
FISTULOGRAM( XRAY)
|
500 |
|
|
33
|
FITNESS STATUS
|
10 |
|
|
34 |
FMC 7 |
1250 |
|
|
35
|
FNAC MORE THAN 3 SMEARS
|
500 |
|
|
36 |
FNAC SMEAR(ONE SLIDE)
|
500 |
|
|
37
|
FNAC SMEAR(TWO SLIDE)
|
500 |
|
|
38 |
FOLATE - RBC |
2500 |
|
280.00 - 791.00 ng/mL Folate plays an important role in the synthesis of purine & pyrimidines in the body and is important for the maturation of erythrocytes. It is widely available from plants and to a lesser extent organ meats, but more than half the folate content of food is lost during cooking.
Folate deficiency is commonly prevalent in alcoholic liver disease, pregnancy and the elderly. It may result from poor intestinal absorption, nutrition deficiency, excessive demand as in pregnancy or in malignancy and in response to certain drugs like Methotrexate & anticonvulsants. RBC folate concentration is indicative of tissue stores. It reflects the folate status over a period of 120 days.
|
39
|
FOLIC ACID |
600 |
1 ml
|
Normal : 3.89 - 26.8 ng/ml Deficient : 0.00 - 1.40 ng/ml
|
40 |
FOLLICULAR STUDY
|
1000 |
|
|
41
|
FOOD ALLERGENS |
4000 |
2 ml
|
CLASS 0 [0.00 - 0.35 KU/l]: NOT PRESENT CLASS 1 [0.35 - 0.70 KU/l]: LOW THRESHOLD CLASS 2 [0.70 - 3.50 KU/l]: SLIGHT INCREASE CLASS 3 [3.50 - 17.5 KU/l]: SIGNIFICANTLY INCREASED CLASS 4 [17.50- 50.0 KU/l]: HIGH CLASS 5 [50.0 - 100.0 KU/l]: VERY HIGH CLASS 6 [> 100.0 KU/l ] : EXTREMELY HIGH
|
42 |
FOOD INTOLERANCE TEST 200 + ( FIT- IgG) |
15000 |
|
|
43
|
FOOD INTOLERANCE TEST 200 + ( FIT _ IgG) |
15000 |
|
|
44 |
FOODPRINT -200 |
15000 |
|
|
45
|
FOOT AP /LAT VIEW (LEFT)
|
300 |
|
|
46 |
FOOT AP/LAT VIEW (RIGHT)
|
300 |
|
|
47
|
FOOT AP/OBLIQUE VIEW (LEFT)
|
300 |
|
|
48 |
FOOT AP/OBLIQUE VIEW (RIGHT)
|
300 |
|
|
49
|
FOREARM AP / LAT VIEW (LEFT)
|
300 |
|
|
50 |
FOREARM AP/LAT VIEW (RIGHT)
|
300 |
|
|
51
|
FREE T3 |
150 |
1 ML
|
Adult : 2.0 - 4.4 pg/ml
New born : 1.73 - 6.3 pg/ml 6days-3months: 1.95 - 6.04 pg/ml 4 - 12 months: 2.15 - 5.83 pg/ml 1 - 6 Yrs : 2.41 - 5.5 pg/ml 7 -11 Yrs : 2.53 - 5.22 pg/ml 12 -20 yrs : 2.56 - 5.01 pg/ml
|
52 |
FREE PSA |
750 |
0.5 ml
|
Free PSA should always be done along with Total PSA and not alone, and expressed as RAtio of Total PSA.
Higher Free PSA:Total PSA ratios indicate a benign tumour , and a lower Ratio indicates the possibility of Malignancy.
Diagnosis must be confirmed by correlating with other Clinical Findings and Biopsy.
|
53
|
FREE T4 |
150 |
0.5 ML
|
New born : 0.86 - 2.49 ng/dl 6days-3months: 0.89 - 2.20 ng/dl 4 - 12 months: 0.92 - 1.99 ng/dl 1 - 6 Yrs : 0.96 - 1.77 ng/dl 7 -11 Yrs : 0.97 - 1.67 ng/dl 12 -20 yrs : 0.98 - 1.63 ng/dl
Adult : 0.93 - 1.7 ng/dl
Pregnancy:
First Trimester : 0.9-1.5 ng/dl Second Trimester: 0.8-1.3 ng/dl Third Trimester : 0.7-1.2 ng/dl
|
54 |
Free Androgen Index / Free Testosterone Index |
1500 |
|
Male
20-49 yrs : 35.0 - 92.6 % >50 Yrs : 24.3 - 72.1 %
Female
20 - 49 Yrs : 0.297 - 5.62 % >50 Yrs : 0.187 - 3.63 %
|
55
|
FREE BETA HCG |
600 |
|
|
56 |
Free Kappa / Lambda Light Chain - Urine |
7000 |
|
|
57
|
Free Kappa /Lambda Ratio |
0 |
|
Without Renal involvement: 0.26 - 1.65
With Renal involvement: 0.37 - 3.1
To be interpreted along with Protein EPP, IFE, Bone marrow studies, and Beta 2 Microglobulin levels in the assessment of Multiple Myeloma.
|
58 |
Free Kappa Light Chain |
2500 |
0.5 ml
|
3.30 to 19.40 mg/L Elevations of Monoclonal Free Light chains are seen in Multiple Myeloma, AL Amyloidosis, Light Chain Deposition Disease. Polyclonal Free Light Chians are increased in SLE. Kappa/Lambda ratio is more useful in classifying MM than separate FLC.
|
59
|
Free Lambda Light Chain |
2500 |
0.5 ml
|
5.71 to 26.30 mg/L Elevations of Monoclonal Free Light chains are seen in Multiple Myeloma, AL Amyloidosis, Light Chain Deposition Disease. Polyclonal Free Light Chians are increased in SLE. Kappa/Lambda ratio is more useful in classifying MM than separate FLC.
|
60 |
FREE TESTOSTERONE |
1000 |
1 ML
|
Prepubertal Male : 1.4 - 14.0 pg/ml
Males(20 - 39 Yrs) : 8.90-42.5 pg/ml
Male (40 - 59 Yrs) : 6.6 - 30 pg/ml Above 60 yrs : 4.9 - 21.6pg/ml Females (20 -39 Yrs) : 0.02- 3.09 pg/ml
Female (40 - 59 Yrs) : 0.02 - 2.6 pg/ml
Above 60 yrs : 0.02 - 1.8 pg/ml
|
61
|
FRUCTOSAMINE - SERUM |
600 |
|
202 - 282 umol/L
Clinical Use ------------ 1. Monitor short term glucose control (1-2 weeks) in patients with Diabetes. 2. Manage patients with Gestational diabetes. 3. Determine the success in change in therapy in less time than is possible with Glycated Hemoglobin. 4. Monitor diabetic control in patients with hemolytic anemias.
Increased Levels : 1.Uncontrolled Diabetes. 2.Hyperglycemia.
Decreased Levels : Relatively with improved diabetic control.
|
62 |
Fructose
|
0 |
|
|
63
|
FSC
|
0 |
|
|
64 |
FSH |
300 |
1 ML
|
FEMALES Follicular Phase : 3.5 - 12.5 mIu/ml. Ovulation Phase : 4.7 - 21.5 mIu/ml. Luteal Phase : 1.7 - 7.7 mIu/ml. Postmenopausal :25.8 - 134.8 mIu/ml. MALE 13 - 70 Years : 1.5 - 12.4 mIu/ml.
|
65
|
FTA - ABS IGM |
2500 |
1 ml
|
|
66 |
FTA - ABS SERUM |
2500 |
|
|
67
|
FTA - ABS IGG |
2500 |
1 ml
|
|
68 |
FTA - ABS (CSF) |
500 |
|
|
69
|
Functional Sperm
|
0 |
|
|
70 |
FUNGUS CULTURE
|
600 |
|
|
71
|
FX5 FOOD PANEL ALLERGEN SCREEN |
2000 |
1. ML
|
Fx5 Food panel includes Allergens for Egg white, egg yolk,milk,Fish,Wheat and Soya bean
|